Skip to main content

Articles

Page 1 of 73

  1. Insulin resistance (IR) and metabolic syndrome (MetS) are significant global health challenges that increase the risk of various chronic diseases. The lymphocyte-to-high-density lipoprotein cholesterol ratio (...

    Authors: Junwei Guo, Kelibinuer Mutailipu, Xin Wen, Jiajing Yin, Hui You, Shen Qu, Haibing Chen and Le Bu
    Citation: Lipids in Health and Disease 2025 24:9
  2. Clinical studies have suggested that tirzepatide may also possess hepatoprotective effects; however, the molecular mechanisms underlying this association remain unclear. In our study, we performed biochemical ...

    Authors: Jinliang Liang, Huanyi Liu, Guo Lv, Xiaotong Chen, Zhaoshou Yang, Kunhua Hu and Hongyan Sun
    Citation: Lipids in Health and Disease 2025 24:8
  3. The Cardiometabolic Index (CMI) represents a novel anthropometric measurement, which combines characteristics of adiposity and lipids. Since obesity, lipid metabolism, and inflammation may collectively facilit...

    Authors: Fangfang Li, Yu He, Ali Yang, Mingrong Xia, Weizhou Zang and Jiewen Zhang
    Citation: Lipids in Health and Disease 2025 24:7
  4. Nutrition and its associated inflammation have been acknowledged as vital factors in the etiopathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis. The nutritional risk index (NRI) has b...

    Authors: Jieming Jian, Rui Zhang, Yuan Dong, Hongting Zheng and Xiaoyu Liao
    Citation: Lipids in Health and Disease 2025 24:6
  5. Metabolic dysfunction-associated steatotic liver disease (MASLD) is an asymptomatic, multifaceted condition often associated with various risk factors, including fatigue, obesity, insulin resistance, metabolic...

    Authors: Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya and Revathi P. Shenoy
    Citation: Lipids in Health and Disease 2025 24:5
  6. Prior research indicates a potential link between dyslipidemia and endometriosis (EMs). However, the relationship between remnant cholesterol (RC) and EMs has not been thoroughly investigated. Consequently, lo...

    Authors: Zeru Chen, Ruixuan Li, Jiajie Guo, Xiaorong Ye, Yang Zhou and Mingzhu Cao
    Citation: Lipids in Health and Disease 2025 24:2
  7. Intra-pancreatic fat deposition (IPFD) is linked to metabolic and pancreatic diseases. MRI, while precise, is not cost-effective for routine IPFD screening, highlighting the need for accessible biomarkers. Thi...

    Authors: Ting Ran, Yanni Wang, Fengxi Yuan, Ruoyi Liu, Meng Ye, Miao Zhang, Xia Du and Jing Zheng
    Citation: Lipids in Health and Disease 2025 23:384
  8. The fat mass and obesity-associated protein (FTO) has been showed to be involved in the pathogenesis and progression of coronary artery disease (CAD). However, the effects of FTO variants on CAD risk remain poorl...

    Authors: Xue Min, Yu-Lan Zhou, Yun-Fei Qu, Zhao-Fu Liao, Heng Li, Jie Cheng, Li-Li Liang, Hai-Liang Mo, Zhu-Guo Wu and Xing-Dong Xiong
    Citation: Lipids in Health and Disease 2025 24:1
  9. With metabolic disorders on the rise globally, the cardiometabolic index (CMI) has emerged as a crucial predictor of mortality risks linked to cancer, cardiovascular disease, and diabetes. This novel index, wh...

    Authors: Junjie Wang, Li Xiao and Zhou Li
    Citation: Lipids in Health and Disease 2024 23:427
  10. Excessive submental fat under the chin is a known aesthetic concern because of its negative impact on facial appearance and psychological well-being. AYP-101 is a newly developed injectable agent containing 93...

    Authors: Hyun Joon Lee, Xu Jiang, A. M. Abd El-Aty, Ji Hoon Jeong and Jae-Yong Chung
    Citation: Lipids in Health and Disease 2024 23:426
  11. Cardiometabolic index (CMI) is a comprehensive clinical parameter which integrates overweight and abnormal lipid metabolism. However, its relationship with all-cause, cardiovascular disease (CVD), and cancer m...

    Authors: Mingjie Liu, Chendong Wang, Rundong Liu, Yan Wang and Bai Wei
    Citation: Lipids in Health and Disease 2024 23:425
  12. There is still no reliable therapeutic _targets and effective pharmacotherapy for metabolic dysfunction-associated steatotic liver disease (MASLD). RASD1 is short for Ras-related dexamethasone-induced 1, a pivo...

    Authors: Guifang Zeng, Xialei Liu, Zhouying Zheng, Jiali Zhao, Wenfeng Zhuo, Zirui Bai, En Lin, Shanglin Cai, Chaonong Cai, Peiping Li, Baojia Zou and Jian Li
    Citation: Lipids in Health and Disease 2024 23:424
  13. Familial hypercholesterolemia (FH) is an inherited disorder mainly marked by increased low-density lipoprotein cholesterol (LDL-C) concentrations and a heightened risk of early-onset arteriosclerotic cardiovas...

    Authors: Meng-Na Huang, Chen-Cen Wang, Ming-Sheng Ma, Mei-Zhu Chi, Qing Zhou, Li-Hong Jiang, Chun-Lin Wang, Mei Lu, Xiao-Quan Chen, Ya-Ying Cheng, Qing Ke, Da-Yan Wang, Xiao-Xia Qian, Xiao-Ming Ying, Jian-Ping Zhang, Qun-Hua Shen…
    Citation: Lipids in Health and Disease 2024 23:423
  14. Lipid metabolism is influenced by mutations in the EH domain binding protein 1 gene (EHBP1). This study investigated the link between the EHBP1 single-nucleotide polymorphisms (SNPs) and dyslipidemia risks in mai...

    Authors: Yan-Fei Lai, Zhong-E Liang, Chun-Xiang Wu, Min Zhang, Zong-Hu Shi, Xiao-Yan Meng and Chun-Xiao Liu
    Citation: Lipids in Health and Disease 2024 23:422
  15. Universal lipid screening in childhood for early detection and treatment of familial hypercholesterolemia is under discussion, but will also detect children with multifactorial dyslipidemia. Results from popul...

    Authors: Julia Truthmann, Anja Schienkiewitz, Antje Kneuer, Yong Du and Christa Scheidt-Nave
    Citation: Lipids in Health and Disease 2024 23:421
  16. Authors: Daniel L. Pontzen, Martin Bahls, Diana Albrecht, Stephan B. Felix, Marcus Dörr, Till Ittermann, Matthias Nauck and Nele Friedrich
    Citation: Lipids in Health and Disease 2024 23:420

    The original article was published in Lipids in Health and Disease 2023 22:100

  17. Postmenopausal women are more susceptible to stress urinary incontinence (SUI), and insulin resistance (IR) is closely related to SUI. The triglyceride-glucose (TyG) index is an efficient metric for assessing ...

    Authors: Xueping Huang, Wen Hu and Limei Li
    Citation: Lipids in Health and Disease 2024 23:419
  18. Frailty poses a considerable public health challenge because of its association with negative health consequences. Although obesity is recognized as a contributor to frailty, conventional measures fail to adeq...

    Authors: Shaohua Yan, Ke Chai, Jiefu Yang and Hua Wang
    Citation: Lipids in Health and Disease 2024 23:417
  19. Life’s Simple 7 (LS7), developed by the American Heart Association, addresses seven key health behaviors and relationship factors. Although LS7 has been studied in relation to various chronic diseases, its ass...

    Authors: Huan Chen, Zhao Wang, Ning Du, Jinseok Oh, Jing Xu, Rongcan Liu, Junlong Song, Junsheng Zhang and Chan Kang
    Citation: Lipids in Health and Disease 2024 23:415
  20. We determined utilizing a sepsis participant cohort whether there is a significant association between TyG-BMI (triglyceride glucose body mass index) and mortality rates at any stage.

    Authors: Huijun Jin, Xuefeng Xu, Chun Ma, Xinghai Hao and Jinglan Zhang
    Citation: Lipids in Health and Disease 2024 23:414
  21. The aim of this study was to evaluate the association between simple, combined lipid biomarkers, and 20-year cumulative incidence of new type 2 diabetes mellitus (T2DM) among adults participating in the ATTICA...

    Authors: Ioanna Kechagia, Fotios Barkas, Evangelos Liberopoulos, Christina Chrysohoou, Petros P. Sfikakis, Costas Tsioufis, Christos Pitsavos and Demosthenes Panagiotakos
    Citation: Lipids in Health and Disease 2024 23:413
  22. Diabesity, a co-occurrence of diabetes and obesity, is a growing public health concern globally. The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, has been associated with various...

    Authors: Fan Zhang, Yan Sun, Yan Bai, Rong Wu and Hua Yang
    Citation: Lipids in Health and Disease 2024 23:412
  23. Obesity and insulin resistance (IR) may be risk factors for thyroid disease, but there is no clinical-based consensus on this topic. Therefore, this study aims to evaluate the associations between the triglyce...

    Authors: Ya-Jie Zhai, Chen-Ying Lin, Jing-Bo Li, Hui-Na Qiu, Fan Wu, Yu-Lun Wang and Jing-Na Lin
    Citation: Lipids in Health and Disease 2024 23:411
  24. Although dyslipidemia has been acknowledged as a risk factor for Alzheimer’s disease (AD), the effects of lipid-lowering drugs on AD have not been determined. The primary pathophysiological hallmark of AD is t...

    Authors: Liangjun Dang, Shan Wei, Yi Zhao, Rong Zhou, Suhang Shang, Fan Gao, Jingyi Wang, Jin Wang and Qiumin Qu
    Citation: Lipids in Health and Disease 2024 23:410
  25. The uric acid to high-density lipoprotein cholesterol ratio (UHR) has emerged as a novel metabolic marker and is proven to be associated with diabetes risk. However, there is still a lack of systematic researc...

    Authors: Jianming Yin, Chuanjie Zheng, Zhan Li, Ying Chang, Lingyong Cao and Yiqian Qu
    Citation: Lipids in Health and Disease 2024 23:409
  26. Cardiovascular-kidney-metabolic (CKM) syndrome is characterized as a systemic disease resulting from the pathophysiological interplay among metabolic risk factors, chronic kidney disease (CKD), and cardiovascu...

    Authors: Jiao Tang, Zhehao Xu, Li Ren, Jiahua Xu, Xin Chen, Yian Jin, Ruiyun Liang and Huanji Zhang
    Citation: Lipids in Health and Disease 2024 23:408
  27. Inhibiting cholesterol metabolism has shown great potential in non-small cell lung cancer (NSCLC). However, the regulatory mechanism of the lipid metabolism key factor Sect. 14-like lipid binding 2 (SEC14L2) i...

    Authors: Qianhui Zhou, Dianwu Li, Yanchao Liang, Yunzhu Long and Yi Liu
    Citation: Lipids in Health and Disease 2024 23:407
  28. Childhood-onset systemic lupus erythematosus (cSLE) is associated with significant morbidity and mortality. Dyslipidemia and metabolic syndrome are recognized risk factors for premature atherosclerosis. This s...

    Authors: Sirin Nuntasri, Sirirat Charuvanij, Kraisoon Lomjansook, Puthita Saengpanit, Kwanjai Chotipanang and Maynart Sukharomana
    Citation: Lipids in Health and Disease 2024 23:406
  29. High-intensity interval training (HIT) does not burn fat during exercise. However, it significantly reduces visceral adipose after long-term training. The underlying mechanism may be related to the elevation o...

    Authors: Baishuo Cheng, Jinchan Du, Shuai Tian, Zixiong Zhang, Wei Chen and Yang Liu
    Citation: Lipids in Health and Disease 2024 23:405
  30. Previous studies have established a correlation between elevated levels of remnant cholesterol (RC) and the occurrence of type 2 diabetes mellitus (T2D) as well as insulin resistance (IR); however, the precise...

    Authors: Yuying Li, Qiao Zeng, Danping Peng, Pingsheng Hu, Jiahua Luo, Keyang Zheng, Yuzhe Yin, Rite Si, Jingyi Xiao, Shaofen Li, Jinxiang Fu, Jinping Liu and Yuqing Huang
    Citation: Lipids in Health and Disease 2024 23:404
  31. This study aimed to investigate the associations between noninsulin-dependent insulin resistance indices (NI-IRIs), including the triglyceride-glucose (TyG) index, TyG-BMI, triglyceride-to-high-density lipopro...

    Authors: Zhentao Qiao, Yuansong Zhuang and Zhiwei Wang
    Citation: Lipids in Health and Disease 2024 23:403
  32. Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with many aspects of disturbed metabolic health. MASLD encompasses a wide spectrum of liver diseases, ranging from isolate...

    Authors: Clément J. F. Heymann, Anne Linde Mak, Adriaan G. Holleboom, Joanne Verheij, Ronit Shiri-Sverdlov, Saskia W. C. van Mil, Maarten E. Tushuizen, Ger H. Koek and Aldo Grefhorst
    Citation: Lipids in Health and Disease 2024 23:402
  33. Research has indicated that treatment with rosuvastatin can improve liver pathology in metabolic-associated fatty liver disease (MAFLD) patients and that treatment with Bifidobacterium can improve MAFLD. Therefor...

    Authors: Xue Ran, Ying-jie Wang, Shi-gang Li and Chi-bing Dai
    Citation: Lipids in Health and Disease 2024 23:401
  34. Klotho, an anti-aging protein, is linked to energy metabolism. There is limited research on the association of serum klotho and triglyceride glucose (TyG) index-related indicators. Our research aims to investi...

    Authors: Yaoyao Zhou, Yaqi Wang, Fangli Li, Yiming Shi, Taotao Wu and Yingshuai Li
    Citation: Lipids in Health and Disease 2024 23:399
  35. Previous studies have shown that metabolic imbalances contribute to digestive diseases. This study aimed to investigate the relationship of the atherogenic index of plasma (AIP) and modified triglyceride-gluco...

    Authors: Tiantian Gao, Mudan Ren, Yun Feng, Yarui Li, Xv Zhang and Shuixiang He
    Citation: Lipids in Health and Disease 2024 23:398
  36. The association of a combination of the TyG index and obesity markers, specifically waist circumference (WC), with cognitive function is unknown. This research investigated the relationship between TyG-WC meas...

    Authors: Juan Hao, Yuting Lu, Lei Zhang, Xiao Li, Haotian Wen, Xiyu Zhao, Lifeng Wang, Jun Tu, Jinghua Wang, Chunsheng Yang, Xianjia Ning and Yan Li
    Citation: Lipids in Health and Disease 2024 23:397
  37. Resolvins, which are divided into series D (RvD) and E (RvE), originate from omega-3 fatty acids, DHA and EPA and were recently found to be involved in the modulation of inflammation in some tumors, including ...

    Authors: Alessio Molfino, Giovanni Imbimbo, Gerardo Salerno, Luana Lionetto, Alessandro De Luca, Maria Ludovica Costanzo, Maurizio Simmaco, Maurizio Muscaritoli and Maria Ida Amabile
    Citation: Lipids in Health and Disease 2024 23:396
  38. Metabolic dysfunction-associated steatosis liver disease (MASLD) is one of the most common metabolic liver diseases around the world, whose prevalence continues to increase. Currently, there are few medication...

    Authors: Xiaoyu Lv, Chenyu Nie, Yihan Shi, Qincheng Qiao, Jing Gao, Ying Zou, Jingwen Yang, Li Chen and Xinguo Hou
    Citation: Lipids in Health and Disease 2024 23:395
  39. Dyslipidemia plays a pivotal role in the development of diabetes mellitus (DM) and other metabolic disorders. This study aimed to investigate the trends in lipid concentrations among Chinese participants with ...

    Authors: Mengjie Zhao, Yurong Cheng, Mengxuan Li, Wantong Zhang, Jinjin Ji and Fang Lu
    Citation: Lipids in Health and Disease 2024 23:394
  40. Metabolic Syndrome (MetS) is characterized by the co-occurrence of various metabolic risk factors, significantly increasing the risk of cardiovascular diseases (CVD) and type 2 diabetes (T2DM). This study inve...

    Authors: Seyyed Mohammad Hashemi, Masoumeh Kheirandish, Shideh Rafati, Arezoo Ghazalgoo, Ehsan Amini-Salehi, Mohammad-Hossein Keivanlou, Shahin Abbaszadeh, Parsa Saberian and Arash Rahimi
    Citation: Lipids in Health and Disease 2024 23:393
  41. Insulin resistance (IR) is a recognized contributor to stroke association, and the estimated glucose disposal rate (eGDR) is a dependable indicator of IR. However, the specific connections between eGDR, stroke...

    Authors: Yutong Han, Kexin Zhang, Yue Luo, Bin Wan, Yaowen Zhang, Qinchuan Huang, Hanyu Liu, Yulin Leng and Chunguang Xie
    Citation: Lipids in Health and Disease 2024 23:392
  42. Cancer is a significant health challenge and the leading cause of mortality globally. Tumor cells use multiple mechanisms to acquire their distinctive capacity for uncontrolled proliferation, one of which is t...

    Authors: Fiorella J. Ferremi, Veronica V. Moscoso, Mauro A. Montanaro, Maria R. Gonzalez-Baro and Elizabeth R. Cattaneo
    Citation: Lipids in Health and Disease 2024 23:391
  43. The intake of dietary antioxidants and glycolipid metabolism are closely related to chronic kidney disease (CKD), particularly among individuals with abdominal obesity. Nevertheless, the cumulative effect of m...

    Authors: Xiangling Deng, Lifei Ma, Pin Li, Mengyang He, Ruyue Jin, Yuandong Tao, Hualin Cao, Hengyu Gao, Wenquan Zhou, Kuan Lu, Xiaoye Chen, Wenchao Li and Huixia Zhou
    Citation: Lipids in Health and Disease 2024 23:390
  44. The ZJU index is an innovative computational method which integrates BMI, FBG, TG, and ALT to AST ratio. It strongly correlates with measures of lipid metabolism and glucose intolerance. No researches have yet...

    Authors: Jia-qi Hao, Shu-yue Hu, Zi-xuan Zhuang, Jia-wan Zhang, Meng-rui Xiong, Rui Wang, Wen Zhuang and Mo-jin Wang
    Citation: Lipids in Health and Disease 2024 23:389
  45. Patients with betathalassemia have higher risk of various metabolic disturbances. The literature presents conflicting results about the patterns of abnormal lipid profile among patients with betathalassemia. T...

    Authors: Sagad O. O. Mohamed, Ali E.A. Mohamed, Mohamed S.K. Salih, Khalid S.K. Salih, Ahmed S.E.E. Abdelrahman, Ahmed G.A. Abdelgadir, Mona G.A. Ahmedkaroum, Gehad A. Abdalla, Hanaa A.M. Fadil, Mahmoud A.M. Abdelrahman and Nehal S.A. Salih
    Citation: Lipids in Health and Disease 2024 23:388

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.9
    5-year Journal Impact Factor: 4.3
    Source Normalized Impact per Paper (SNIP): 1.220
    SCImago Journal Rank (SJR): 1.112

    Speed 2023
    Submission to first editorial decision (median days): 1
    Submission to acceptance (median days): 68

    Usage 2023
    Downloads: 1,810,907
    Altmetric mentions: 1,488

  NODES
admin 1
Association 30
Note 2
twitter 1